XML 58 R31.htm IDEA: XBRL DOCUMENT v3.23.3
SHARE BASED COMPENSATION
 12 Months Ended
Sep. 30, 2023
Share-Based Payment Arrangement [Abstract]  
SHARE BASED COMPENSATION SHARE BASED COMPENSATION
Equity based incentive and performance compensation awards provided to employees, directors, officers and consultants, including the restricted stock units and stock options further discussed below, were issued pursuant to the Spectrum Brands Holdings, Inc. 2011 Omnibus Equity Awards Plan as approved and amended by the Spectrum Legacy stockholders, and the Spectrum Brands Holdings, Inc. 2020 Omnibus Equity Plan, as approved by the Spectrum stockholders. The following is a summary of the authorized and available shares per the respective plans:
(number of shares, in millions)AuthorizedAvailable
Spectrum Brands Holdings, Inc. 2011 Omnibus Equity Awards Plan7.1 0.2 
Spectrum Brands Holdings, Inc. 2020 Omnibus Equity Plan2.6 2.1 
During the year ended September 30, 2023, the Company amended and restated its 2020 Omnibus Equity Plan to increase the maximum number of shares of common stock available for issuance. The amendment to the 2020 Omnibus Equity Plan authorized the issuance of up to an additional 1.4 million shares of common stock of Spectrum Brands Holdings, Inc., effective August 8, 2023.
Compensation costs for share-based payment arrangements are recognized as General and Administrative Expenses on the Consolidated Statements of Income. The following is a summary of the share based compensation expense for the years ended September 30, 2023, 2022 and 2021:
(in millions)202320222021
SBH$17.2 $10.2 $28.9 
SB/RH$15.7 $9.1 $27.2 
Restricted Stock Units ("RSUs")
The Company recognizes share based compensation expense from the issuance of RSUs, primarily under its Long-Term Incentive Plan ("LTIP"). RSUs granted under the LTIP include a combination of time-based grants and performance-based grants. Compensation cost is based on the fair value of the awards, as determined by the market price of the Company’s shares of common stock on the designated grant date and recognized on a straight-line basis over the requisite service period of the awards. Time-based RSUs provide for either a three year cliff vesting or graded vesting depending upon the vesting conditions provided by the grant and the performance-based RSUs are dependent upon achieving specified financial metrics (adjusted EBITDA, return on adjusted equity, and/or adjusted free cash flow) by the end of the three year vesting period. The actual number of shares that will ultimately vest for the performance-based RSUs is dependent on the level of achievement of the specified performance conditions upon completion of the designated performance period. The Company assessed the probability of achievement of the performance conditions and recognized expense for the awards based on the probable achievement of such metrics. Additionally, the Company regularly issues individual RSU awards under its equity plan to its Board members and individual employees for recognition, incentive, or retention purposes, when needed, which are primarily conditional upon time-based service conditions, valued based on the fair value of the awards as determined by the market price of the Company's share of common stock on the designated grant price date and recognized as a component of share-based compensation on a straight-line basis over the requisite service period of the award. RSUs are subject to forfeiture if employment terminates prior to vesting with forfeitures recognized as they occur. RSUs have dividend equivalents credited to the recipient and are paid only to the extent the RSU vests and the related stock is issued. RSUs are exercised upon completion of the vesting conditions. Shares issued upon exercise of RSUs are sourced from treasury shares when available.
The Company regularly issues annual RSU grants under its LTIP during the first quarter of the fiscal year. The following is a summary of the RSUs granted during the fiscal year ending September 30, 2023.
SBH
SB/RH
(in millions, except per share data)
Units
Weighted
Average
Grant Date
Fair Value
Fair
Value
at Grant
Date
Units
Weighted
Average
Grant Date
Fair Value
Fair
Value
at Grant
Date
Time-based grants
Vesting in less than 12 months0.13 $56.66 $7.3 0.10 $58.76 $5.8 
Vesting in more than 12 months0.14 50.85 7.2 0.14 50.85 7.2 
Total time-based grants0.27 53.60 14.5 0.24 54.08 13.0 
Performance-based grants0.28 50.87 14.1 0.28 50.87 14.1 
Total grants0.55 $52.22 $28.6 0.52 $52.36 $27.1 
The following is a summary of RSU activity for the years ended September 30, 2023, 2022 and 2021:
SBH
SB/RH
(in millions, except per share data)SharesWeighted
Average
Grant Date
Fair Value		Fair
Value
at Grant
Date		SharesWeighted
Average
Grant Date
Fair Value		Fair
Value at Grant
Date
Outstanding and nonvested as of September 30, 20201.40 $56.41 $79.3 1.38 $56.33 $77.7 
Granted0.59 76.78 44.9 0.56 76.83 43.3 
Forfeited(0.20)65.52 (13.2)(0.20)65.52 (13.2)
Vested and exercised(0.33)53.53 (17.8)(0.30)52.82 (16.2)
Outstanding and nonvested as of September 30, 20211.46 64.00 93.2 1.44 63.85 91.6 
Granted0.33 95.30 32.3 0.32 95.24 31.2 
Forfeited(0.18)78.90 (13.8)(0.18)78.90 (13.8)
Vested and exercised(0.60)55.09 (33.4)(0.60)54.34 (31.8)
Outstanding and nonvested as of September 30, 20221.01 77.22 78.3 0.98 77.03 77.2 
Granted0.55 52.22 28.6 0.52 52.36 27.1 
Forfeited(0.21)71.99 (15.0)(0.21)71.99 (15.0)
Vested and exercised(0.46)70.98 (32.7)(0.44)70.33 (31.6)
Outstanding and nonvested as of September 30, 20230.89 $66.29 $59.2 0.85 $66.87 $57.7 
As of September 30, 2023, the remaining unrecognized pre-tax compensation cost associated with outstanding RSUs is $38.6 million for both SBH and SB/RH that would expected to be recognized over a weighted average period of 1.4 years for SBH and SBRH, contingent upon realization of performance goals for performance based grants. If performance goals are not met, compensation cost may be not recognized, and previously recognized compensation cost would be reversed.

Stock Options
All stock options awards are fully vested and exercisable. The Company does not regularly grant new stock option awards and there were no awards granted during the years ended September 30, 2023, 2022 and 2021. Shares issued upon exercise of stock option awards are sourced from treasury shares when available. The following is a summary of outstanding stock option awards during the years ended September 30, 2023, 2022, and 2021:
Stock Options
(in millions, except per share data)OptionsWeighted
Average
Exercise
Price
Weighted
Average
Grant Date Fair Value
Vested and exercisable at September 30, 2020$0.22 $73.96 $4.82 
Exercised(0.06)52.83 3.55 
Vested and exercisable at September 30, 20210.16 82.36 5.32 
Vested and exercisable at September 30, 20220.16 82.36 5.32 
Vested and exercisable at September 30, 2023$0.16 $82.36 $5.32 
No options were exercised during the years ended September 30, 2023 and 2022. The intrinsic value of share options exercised during the year ended September 30, 2021 was $2.5 million, with cash received from the options exercises of $3.4 million. As of the year ended September 30, 2023, the aggregate intrinsic value of outstanding and exercisable options was $0.4 million, with the remaining contractual term of 1.3 years